[HTML][HTML] Autoantibodies in idiopathic inflammatory myopathies: clinical associations and laboratory evaluation by mono-and multispecific immunoassays

…, JB Vulsteke, CW Tseng, ACM Platteel, Y Piette… - Autoimmunity …, 2019 - Elsevier
Idiopathic inflammatory myopathies (IIM) are a group of diseases characterized by immune-mediated
muscular lesions that may be associated with extra-muscular manifestations …

Nailfold capillaroscopy in systemic lupus erythematosus: a systematic review and critical appraisal

…, S Decuman, U Müller-Ladner, Y Piette… - Autoimmunity …, 2018 - Elsevier
Nailfold capillaroscopy is an easy, non-invasive technique to assess microvascular involvement
in rheumatic diseases. Multiple studies describe capillaroscopic changes in systemic …

Nailfold capillaroscopy and clinical applications in systemic sclerosis

…, AC Trombetta, C Pizzorni, B Ruaro, Y Piette… - …, 2016 - Wiley Online Library
Capillary microscopy is a safe and non‐invasive tool to evaluate the morphology of the
microcirculation typically affected in SSc. Next to being paramount for the “(very) early” diagnosis …

[HTML][HTML] RORγt inhibition selectively targets IL-17 producing iNKT and γδ-T cells enriched in Spondyloarthritis patients

…, G Varkas, H Cypers, R Wittoek, Y Piette… - Nature …, 2019 - nature.com
Dysregulated IL-23/IL-17 responses have been linked to psoriatic arthritis and other forms of
spondyloarthritides (SpA). RORγt, the key Thelper17 (Th17) cell transcriptional regulator, is …

Nailfold capillaroscopy for prediction of novel future severe organ involvement in systemic sclerosis

…, E Deschepper, C Bonroy, A Sulli, Y Piette… - The Journal of …, 2013 - jrheum.org
Objective. Assessment of associations of nailfold videocapillaroscopy (NVC) scleroderma (systemic
sclerosis; SSc) (“early,” “active,” and “late”) with novel future severe clinical …

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a …

…, PC Robinson, B Dahou, E Rath, Y Piette… - The Lancet …, 2021 - thelancet.com
Background Patients with primary systemic vasculitis or polymyalgia rheumatica might be at
a high risk for poor COVID-19 outcomes due to the treatments used, the potential organ …

Two-year results of an open pilot study of a 2-treatment course with rituximab in patients with early systemic sclerosis with diffuse skin involvement

V Smith, Y Piette, JT Van Praet, S Decuman… - The Journal of …, 2013 - jrheum.org
Objective. To study safety and potential efficacy of a 2-treatment course (month 0/6) with
rituximab (RTX) in early diffuse systemic sclerosis (dcSSc). Methods. Two years’ followup (open-…

Screening for pulmonary arterial hypertension in an unselected prospective systemic sclerosis cohort

…, S Decuman, C Bonroy, Y Piette… - European …, 2017 - Eur Respiratory Soc
Screening for pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) improves
outcomes. The DETECT screening algorithm is recommended in a high-risk SSc subgroup. …

Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies.

…, F Furini, M Giannini, L Damian, Y Piette… - Clinical and …, 2022 - europepmc.org
Clinical spectrum time course in non-Asian patients positive for anti-MDA5 antibodies. - Abstract
- Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …

Is laser speckle contrast analysis (LASCA) the new kid on the block in systemic sclerosis? A systematic literature review and pilot study to evaluate reliability of LASCA …

…, E Deschepper, C Ickinger, K Melsens, Y Piette… - Autoimmunity …, 2018 - Elsevier
Objectives A reliable tool to evaluate flow is paramount in systemic sclerosis (SSc). We
describe herein on the one hand a systematic literature review on the reliability of laser speckle …